• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白溶解的生理和药理学意义。

Physiologic and pharmacologic implications of fibrinolysis.

作者信息

Kwaan H C

出版信息

Artery. 1979 Mar;5(3):285-90.

PMID:526134
Abstract

According to the thrombogenetic (encrustation) theory of atherogenesis first postulated by Rokitansky, accretions of blood components including fibrin and platelets may be the initial event. Since fibrinolysis has a profound influence on the resolution of fibrin deposits, the role of fibrinolysis in atherogenesis is discussed. Evidences supporting this role include the demonstration of inhibitors of fibrinolysis, decreased circulating fibrinolytic activity in patients who are atherosclerotic, and inhibition of circulating fibrinolytic activity by several atherosclerosis-risk factors such as increasing age, cigarette smoking, hypercholesterolemia, hypertriglyceridemia and diabetes mellitus. It is concluded that a combination of systemic inhibitions of fibrinolysis over a long-term period and a local vascular injury, play a decided role in atherogenesis.

摘要

根据罗基坦斯基首次提出的动脉粥样硬化血栓形成(结痂)理论,包括纤维蛋白和血小板在内的血液成分的积聚可能是初始事件。由于纤维蛋白溶解对纤维蛋白沉积物的溶解有深远影响,因此讨论了纤维蛋白溶解在动脉粥样硬化形成中的作用。支持这一作用的证据包括纤维蛋白溶解抑制剂的证明、动脉粥样硬化患者循环纤维蛋白溶解活性降低,以及年龄增长、吸烟、高胆固醇血症、高甘油三酯血症和糖尿病等几种动脉粥样硬化危险因素对循环纤维蛋白溶解活性的抑制。得出的结论是,长期全身性纤维蛋白溶解抑制与局部血管损伤相结合,在动脉粥样硬化形成中起决定性作用。

相似文献

1
Physiologic and pharmacologic implications of fibrinolysis.纤维蛋白溶解的生理和药理学意义。
Artery. 1979 Mar;5(3):285-90.
2
Fibrinolysis and risk factors of atherosclerotic disease, with special emphasis on diabetes mellitus.
Circ Shock. 1978;5(2):125-43.
3
Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.纤维蛋白溶解与凝血抑制的病理生理学及临床方面。特别针对口服避孕药的女性和特定血栓易患人群的实验与临床研究。
Dan Med Bull. 1988 Feb;35(1):1-33.
4
Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.口腔外科中的止血——口腔纤维蛋白溶解对出血可能的发病机制影响。口腔内止血平衡的实验与临床研究,尤其涉及获得性和先天性凝血系统缺陷患者。
Dan Med Bull. 1991 Dec;38(6):427-43.
5
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
6
The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.易发生血栓形成的患者群体中的止血平衡。特别提及心肌梗死患者的纤维蛋白溶解。
Dan Med Bull. 1990 Jun;37(3):210-34.
7
[Endothelium and endogenous fibrinolysis].
Z Kardiol. 2000 Mar;89(3):219-26. doi: 10.1007/s003920050474.
8
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group.纤维蛋白周转增加及纤溶能力缺陷与下肢动脉粥样硬化的关联。PLAT研究组。
Thromb Haemost. 1994 Aug;72(2):292-6.
9
Advances in clinical fibrinolysis.临床纤维蛋白溶解的进展
Clin Haematol. 1986 May;15(2):443-63.
10
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.急性肺损伤中的凝血、纤维蛋白溶解及纤维蛋白沉积
Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB.

引用本文的文献

1
The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.单核苷酸多态性对人α2-抗纤溶酶活性的影响。
Blood. 2007 Jun 15;109(12):5286-92. doi: 10.1182/blood-2007-01-065185. Epub 2007 Feb 22.